The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Journal:

Journal of Clinical Oncology

Published:

2026-03-11

DOI:

10.1200/jco-25-02934

Affiliations:

20

Authors:

36

Go to article

Institutions	Authors	Share
Johns Hopkins University (JHU), United States of America (USA)	6.500000	0.18
Personalis, Inc., United States of America (USA)	4.000000	0.11
Vanderbilt University Medical Center (VUMC), United States of America (USA)	3.000000	0.08
Anne Arundel Medical Center (AAMC), United States of America (USA)	2.000000	0.06
Montefiore Medical Center, Einstein, United States of America (USA)	2.000000	0.06
Duke University Health System, United States of America (USA)	2.000000	0.06
Inova Schar Cancer Institute, United States of America (USA)	1.500000	0.04
UPMC Hillman Cancer Center (UPCI), United States of America (USA)	1.500000	0.04
University of Pennsylvania (Penn), United States of America (USA)	1.500000	0.04
Georgetown Lombardi Comprehensive Cancer Center, United States of America (USA)	1.500000	0.04
Fred Hutchinson Cancer Center, United States of America (USA)	1.333333	0.04
University of Washington (UW), United States of America (USA)	1.333333	0.04
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.03
Melvin and Bren Simon Comprehensive Cancer Center, United States of America (USA)	1.000000	0.03
Baylor College of Medicine (BCM), United States of America (USA)	1.000000	0.03
TidalHealth Peninsula Regional, United States of America (USA)	1.000000	0.03
The University of Chicago (UChicago), United States of America (USA)	1.000000	0.03
The University of Alabama at Birmingham (UAB), United States of America (USA)	1.000000	0.03
University of Michigan Rogel Cancer Center, United States of America (USA)	1.000000	0.03
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	0.833333	0.02

Interested in Oncology and Carcinogenesis?